SecBot SecBot

PRGO

PERRIGO Co plc
NYSE· Pharmaceutical Preparations· Inc. L2· CIK 0001585364 Biotech & Drug Discovery
$16.02 +0.20 (+1.26%)
Oct 27 4:00 PM ET · prev $15.82
Market cap
$2.2B
Mid cap
Median target
$16.00
−0% · range $14.00–20.00
Next earnings
Nov 4
in 8 days
1 year
−25.8%
from $21.60 · Oct 28
30 days
+6.1%
from $15.10
52-week range
$9.25–21.60
−26% from high · low Mar 20
Avg volume 20D
2.43M
shares / day
Short interest
24.18M
≈17.4% of shares · −0.3%
Days to cover
9.0
at average volume
Insider net
$0
no open-market trades · since May 14
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 4, 2026
Strongest MIXED Perrigo reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.35 by 42.9%, but revenue declined…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since May 14. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 43 added (0 new), 29 trimmed or exited.

  • Short sellersSTEADY

    Short interest −0.3% to 24.18M shares. 9.0 days to cover, ≈17.4% of shares.

  • TrendUPTREND

    9% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.ADD22,703,127$235.9M
PRICE T ROWE ASSOCIATES INC /MD/TRIM8,700,421$90.4M
GEODE CAPITAL MANAGEMENT, LLCADD3,622,308$37.6M
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.DOUBLED3,024,213$31.4M
MILLENNIUM MANAGEMENT LLCTRIM2,982,331$31.0M
NORGES BANKTRIM2,014,291$20.9M
AMERICAN CENTURY COMPANIES INCDOUBLED1,880,366$19.5M
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD1,875,868$19.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Feb 2026
12-month targets · 4 analysts

Price is inside the target range. Median implies −0%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Feb 27, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Dec 15, 2025JP Morgan
MAINTAIN
MAINTAINNeutral
Nov 6, 2025Canaccord Genuity
MAINTAIN
MAINTAINBuy
Nov 6, 2025JP Morgan
DOWNGRADE
DOWNGRADENeutral
Oct 27, 2025Jefferies
MAINTAIN
MAINTAINHold
Aug 7, 2025Canaccord Genuity
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · since May 14
DateInsiderTypeValue
Sep 11, 2026
Alford Bradley A
Director
AWARD2,059 sh
Sep 11, 2026
Alford Bradley A
Director
EXERCISE$17.3K
Sep 11, 2026
Alford Bradley A
Director
TAX W/H$8.3K
Sep 11, 2026
Parker Geoffrey M.
Director
EXERCISE$17.3K
Sep 11, 2026
Parker Geoffrey M.
Director
TAX W/H$8.3K
Sep 9, 2026
Ball David
EVP & CBDO
EXERCISE$110.4K
Sep 9, 2026
Ball David
EVP & CBDO
TAX W/H$39.9K
Jul 8, 2026
Khoury Roberto
EVP and President of CSCI
EXERCISE$7.8K

Earnings setup

Estimates
Nov 4
reports in 8 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$0.74$0.64–$0.81-0.6%$1.1B
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

21 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 15, 2026
24,179,053
shares short
-0.3%
vs prior settlement
9.0
days to cover
≈17.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 11, 2026 Insider
Alford Bradley A was granted 2,059 shares
Director
Sep 11, 2026 Insider
Alford Bradley A acquired via exercise 1,263 shares
Director @ $13.66 ($17.3K)
Sep 11, 2026 Insider
Alford Bradley A surrendered for taxes 607 shares
Director @ $13.66 ($8.3K)
Aug 5, 2026 SEC
Perrigo reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.35 by 42.9%, but revenue declined 3.2% YoY to…
8-K — Impact 6/10
Aug 5, 2026 Earnings calendar
PRGO Q2 2026 Earnings Scheduled — 2026-08-05
Jun 30, 2026 SEC
Perrigo appointed Salman Amin and Omer Gajial as independent directors, expanding the board from 8 to 10 members. Both…
8-K — Impact 2/10
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
22,703,127 shares ($235.9M)
Jun 30, 2026 Inst.
PRICE T ROWE ASSOCIATES — TRIM
8,700,421 shares ($90.4M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 4, 2026
Earnings date
PRGO Q3 2026 Earnings Scheduled — 2026-11-04
Recent
Aug 5, 2026
Earnings date
PRGO Q2 2026 Earnings Scheduled — 2026-08-05
Jun 30, 2026
Short interest
Short Interest: PRGO up 40% to 24.6M shares
Settlement 2026-06-30 | Days to cover: 4.67 | ≈17.76% of shares outstanding (est.)
May 11, 2026
Short interest
FTD: PRGO — 101,080 shares ($1.2M) failed to deliver
Settlement: 20260511, Price: $11.71, FTD Value: $1,183,646.8, PERRIGO COMPANY PLC (IRL)
May 6, 2026
Earnings date
PRGO Q1 2026 Earnings Scheduled — 2026-05-06
Mar 2, 2026
Short interest
FTD: PRGO — 88,855 shares ($1.2M) failed to deliver
Settlement: 20260302, Price: $13.22, FTD Value: $1,174,663.1, PERRIGO COMPANY PLC (IRL)

SecBot reports

7 filings · 0 bullish · 1 bearish · 1 mixed · 5 neutral
All PRGO filing & press-release reports (7)